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abstract
 
The sensitivity of K
 
ATP
 
 channels to high-afﬁnity block by sulfonylureas and to stimulation by K
 
1
 
 chan-
nel openers and MgADP (PCOs) is conferred by the regulatory sulfonylurea receptor (SUR) subunit, whereas
ATP inhibits the channel through interaction with the inward rectiﬁer (Kir6.2) subunit. Phosphatidylinositol 4,5-
 
bisphosphate (PIP
 
2
 
) profoundly antagonized ATP inhibition of K
 
ATP
 
 channels expressed from cloned
 
Kir6.2
 
1
 
SUR1 subunits, but also abolished high afﬁnity tolbutamide sensitivity. By stabilizing the open state of the
channel, PIP
 
2
 
 drives the channel away from closed state(s) that are preferentially affected by high afﬁnity tolbuta-
mide binding, thereby producing an apparent loss of high afﬁnity tolbutamide inhibition. Mutant K
 
ATP 
 
channels
(Kir6.2[
 
D
 
N30] or Kir6.2[L164A], coexpressed with SUR1) also displayed an “uncoupled” phenotype with no high
afﬁnity tolbutamide block and with intrinsically higher open state stability. Conversely, Kir6.2[R176A]
 
1
 
SUR1
channels, which have an intrinsically lower open state stability, displayed a greater high afﬁnity fraction of tolbuta-
mide block. In addition to antagonizing high-afﬁnity block by tolbutamide, PIP
 
2
 
 also altered the stimulatory ac-
tion of the PCOs, diazoxide and MgADP. With time after PIP
 
2
 
 application, PCO stimulation ﬁrst increased, and
then subsequently decreased, probably reﬂecting a common pathway for activation of the channel by stimulatory
PCOs and PIP
 
2
 
. The net effect of increasing open state stability, either by PIP
 
2
 
 or mutagenesis, is an apparent “un-
coupling” of the Kir6.2 subunit from the regulatory input of SUR1, an action that can be partially reversed by
 
screening negative charges on the membrane with poly-
 
l
 
-lysine.
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introduction
 
The 10 yr that followed the discovery of ATP-sensitive
 
(K
 
ATP
 
) channels (Noma, 1983) led to the delineation of
complex regulation by intracellular nucleotides and
pharmacological agents (reviewed in Ashcroft, 1988;
Nichols and Lederer, 1991; Terzic et al., 1994). The last
3 yr have seen a renewed interest in the regulation of
ATP-sensitive potassium channels as a result of the
cloning of the constituent subunits (Aguilar-Bryan et
al., 1995; Inagaki et al., 1995, 1996). Uniquely, K
 
ATP
 
channels are normally formed as a complex of sulfo-
 
nylurea receptor (SURx)
 
1
 
 and inward rectiﬁer (Kir6.x)
subunits (Inagaki et al., 1995, 1997; Clement et al.,
1997; Shyng and Nichols, 1997). Recent studies demon-
strate that the Kir6.x subunits form the pore, and con-
trol the hallmark inhibition by ATP (Shyng et al.,
1997a; Tucker et al., 1997, 1998; Drain et al., 1998),
whereas the SURx subunit controls the sensitivity to the
inhibitory sulfonylurea drugs, and to activating nucle-
otide diphosphates and potassium channel opening
drugs (Aguilar-Bryan et al., 1995; Inagaki et al., 1996;
Isomoto et al., 1996; Nichols et al., 1996; Shyng et al.,
1997b; Gribble et al., 1997a,b; Schwanstecher et al.,
1998).
 
Deletion of up to 
 
z
 
36 amino acids from the COOH
terminus of Kir6.2 results in the generation of ATP-sen-
sitive channels in the absence of SURx subunits
(Tucker et al., 1997; Zerangue et al., 1999), but these
channels are not activated by MgADP or potassium
channel openers (PCOs), nor are they inhibited at
high afﬁnity by sulfonylurea drugs, consistent with
these agents acting through the SURx subunit (Gribble
et al., 1997a). MgATP clearly binds to the nucleotide
binding folds of SUR1 (Ueda et al., 1997), and ATP hy-
drolysis seems to be required for binding PCOs
(Schwanstecher et al., 1998) and transduction (Nichols
et al., 1996; Gribble et al., 1997b; Shyng et al., 1997a) of
the stimulatory PCO signal to the channel. The physi-
cal nature of the coupling of SURx to Kir6.x subunits is
essentially unknown at the present time, although in-
triguingly, Clement et al. (1997) demonstrated that
Kir6.2 could be labeled with azido-glibenclamide only
in the presence of SUR1 subunits, consistent with a
tight physical association of the two subunits (Lorenz et
al., 1998). In the present study, we have explored the
functional coupling of SUR1 to Kir6.2 The results dem-
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Abbreviations used in this paper:
 
 Kir, inward rectifier; PCO, potas-
sium channel opener; PIP
 
2
 
, phosphatidylinositol 4,5-bisphosphate;
SUR, sulfonylurea receptor. 
204
 
PIP
 
2
 
 Regulation of K
 
ATP
 
 Channel
 
onstrate that the pharmacological control of K
 
ATP
 
 chan-
nel function through SUR1 subunits can be “uncou-
pled” when the channel open-state stability is in-
creased, either by mutation of the Kir6.2 subunit, or by
manipulation of the phospholipid composition of the
membrane. The results also suggest that nucleotide hy-
drolysis and PCO binding stimulate the channel activity
by a convergent pathway with phosphatidylinositol 4,5-
bisphosphate (PIP
 
2
 
). A preliminary report of these re-
sults was made to the Biophysical Society (annual meet-
ing, Kansas City, MO, February, 1998).
 
methods
 
Molecular Biology
 
Kir6.2 mutations were prepared using PCR methods. Resulting
PCR products were subcloned into the EcoRI-ClaI sites of the
mammalian expression vector pCMV6b. SUR1 was cloned into
the pECE expression vector. The nucleotide sequences of the
mutant Kir6.2 constructs were veriﬁed by ﬂuorescence-based cy-
cle sequencing using AmpliTaq DNA polymerase, FS (Perkin-
Elmer Cetus Corp.), and an ABI PRISM DNA sequencer (Perkin-
Elmer Cetus Corp.).
 
Expression of K
 
ATP
 
 Channels in COSm6 Cells
 
COSm6 cells were plated at a density of 
 
z
 
2.5 
 
3
 
 10
 
5
 
 cells per well
(30-mm six-well dishes) and cultured in Dulbecco’s modiﬁed Ea-
gle medium plus 10 mM glucose (DMEM-HG), supplemented
with fetal calf serum (10%). The next day, cells were transfected
by incubation for 4 h at 37
 
8
 
C in DMEM containing 10% nuse-
rum, 0.4 mg/ml diethylaminoethyl-dextran, 100 
 
m
 
M chloro-
quine, and 5 
 
m
 
g each of pCMV6b-Kir6.2, pECE-SUR1, and
pECE–green ﬂuorescent protein cDNA. Cells were subsequently
incubated for 2 min in HEPES-buffered salt solution containing
DMSO (10%), and returned to DMEM-HG plus 10% FCS. Cells
were assayed for K
 
ATP
 
 currents by patch-clamp measurements,
2–4 d after transfection.
 
Patch-Clamp Measurements
 
Patch-clamp experiments were made at room temperature, in an
oil-gate chamber that allowed the solution bathing the exposed
surface of the isolated patch to be changed rapidly. Micropi-
pettes were pulled from thin-walled glass (WPI Inc.) on a hori-
zontal puller (Sutter Instrument Co.). Electrode resistance was
typically 0.5–1 M
 
V
 
 when ﬁlled with K-INT solution (see below).
Microelectrodes were “sealed” onto cells that ﬂuoresced green
under UV illumination by applying light suction to the rear of
the pipette. Inside-out patches were obtained by lifting the elec-
trode and then passing the electrode tip through the oil-gate.
Membrane patches were voltage-clamped with an Axopatch 1B
patch-clamp ampliﬁer (Axon Inc.). The standard bath (intracel-
lular) and pipette (extracellular) solution used in these experi-
ments (K-INT) had the following composition: 140 mM KCl, 10
mM K-HEPES, 1 mM K-EGTA, pH 7.3. PIP
 
2 
 
was bath sonicated in
ice for 30 min before use. PIP
 
2
 
 was obtained from Boehringer
Mannheim. Tolbutamide, diazoxide, nucleotides, and poly-
 
l
 
-
lysine (mol wt 
 
z
 
 1,000) were purchased from Sigma Chemical
Co. Tolbutamide and diazoxide were dissolved as stock solutions
in DMSO and diluted to 
 
,
 
1% DMSO. All currents were mea-
sured at a membrane potential of 
 
2
 
50 mV (pipette voltage 
 
5
1
 
50 mV). Inward currents at this voltage are shown as upward
deﬂections. Data were normally ﬁltered at 0.5–3 kHz, signals
 
were digitized at 22 kHz (Neurocorder; Neurodata) and stored
on video tape. Experiments were replayed onto a chart recorder,
or digitized into a microcomputer using Axotape software (Axon
Inc.). Off-line analysis was performed using Microsoft Excel pro-
grams. Wherever possible, data are presented as mean 
 
6 
 
SEM.
Microsoft Solver was used to ﬁt data by a least-square algorithm.
 
results
 
High Afﬁnity Sulfonylurea Sensitivity Is Lost After Kir6.2 
NH
 
2
 
-Terminal Deletion
 
Gribble et al. (1997a) reported that tolbutamide inhibi-
tion of Kir6.2
 
1
 
SUR1 coexpressed channels in 
 
Xenopus
 
oocytes is biphasic, consisting of low and high afﬁnity
components. The mechanistic basis of the biphasic re-
sponse to tolbutamide is presently unknown (see 
 
dis-
cussion
 
), but it is clear that high afﬁnity sulfonylurea
interaction is with the SUR1 subunit (Aguilar-Bryan et
al., 1995), whereas a low afﬁnity action may occur
through direct interaction with the Kir6.2 subunit
(Gribble et al., 1997a). As shown in Fig. 1, similar bi-
phasic dose–response curves are seen for both wild-
type Kir6.2
 
1
 
SUR1 (WT
 
1
 
SUR1) channels and for
Kir6.2[K185Q]
 
1
 
SUR1 channels expressed in COSm6
cells. The K185Q mutation in Kir6.2 reduces ATP sen-
sitivity, possibly by altering ATP binding afﬁnity, but
does not affect the ATP-independent open probability
(Tucker et al., 1997; Koster et al., 1999). In contrast,
Kir6.2[
 
D
 
N2-30]
 
1
 
SUR1 channels also have a reduced
ATP sensitivity, which in this case results from open-
state stabilization that is reﬂected by near continuous
bursting at the single channel level (Koster et al.,
1999), and these channels show only low afﬁnity inhibi-
tion by tolbutamide (Fig. 1 A). This raises alternate pos-
sibilities that high afﬁnity tolbutamide block is lacking
from Kir6.2[
 
D
 
N2-30] channels because the NH
 
2
 
 termi-
nus is physically involved in “coupling” to the regula-
tory effects of SUR1, or because the high afﬁnity inhibi-
tory effect of tolbutamide depends on channel open
state stability.
 
High Afﬁnity Sulfonylurea Sensitivity Is Lost After PIP
 
2
 
 
Treatment of Wild-Type Channels
 
We can explore the correlation between tolbutamide
sensitivity and open-state stability
 
2
 
 of the channel by ap-
plying PIP
 
2
 
. PIP
 
2
 
 increases the channel open probabil-
ity by increasing bursting behavior of the single chan-
nel and decreases the sensitivity to ATP (Baukrowitz et
al., 1998; Shyng and Nichols, 1998). Although direct
experimental proof is not available, both actions can be
 
2
 
 The open state stability is the stability of the “bursting” state relative
to a longer closed state that is accessible to ATP. As the open state sta-
bility increases, the open probability increases towards a saturating
level of 
 
z
 
0.9 (i.e., the intraburst open probability), and the 
 
K
 
1/2,ATP
 
increases continually (Shyng et al., 1997a). 
205
 
Koster et al.
 
explained by models in which the action of PIP
 
2
 
 is to
stabilize the channel open or bursting state, with ATP
binding to, and stabilizing, the channel closed state
(Shyng et al., 1997a). As shown in Fig. 2, treatment of
wild-type Kir6.2
 
1
 
SUR1 channels with PIP
 
2
 
 leads to in-
creased overall channel activity
 
3
 
 and loss of ATP sensi-
tivity (Baukrowitz et al., 1998; Shyng and Nichols,
1998). Concomitant with this increase in open-state sta-
bility, there is a gradual and complete loss of high afﬁn-
ity tolbutamide block (Fig. 2, A and C). The rate of loss
of both ATP sensitivity and high tolbutamide sensitivity
(Fig. 2 B) are quite variable from patch to patch. How-
ever, there is a reasonable correlation between the tol-
butamide inhibition and ATP sensitivity (Fig. 2 D).
The loss of high afﬁnity tolbutamide inhibition could
occur because the high afﬁnity component actually
changes afﬁnity (i.e., the real, or apparent, binding af-
ﬁnity of tolbutamide is reduced), or because high afﬁn-
ity binding fails to cause inhibition of channel activity.
 
3
 
The increase in 
 
P
 
o
 
 that occurs after PIP
 
2
 
 application is followed by a
variable, very slow, loss of channel activity over many minutes (“termi-
nal rundown”). Such rundown occurs in the presence or absence of
PIP
 
2
 
. This terminal rundown may occur by channels terminally disap-
pearing from the patch, the open probability estimated by noise analy-
sis (i.e., the open probability of channels that remain functional) does
not decline during this process, as quantified for the record in Fig. 6 A.
Figure 1. Tolbutamide sensitiv-
ity of KATP currents from cells co-
expressing Kir6.2, Kir6.2[DN2-
30], or Kir6.2[K185Q] mutant
subunits and SUR1. (A) Repre-
sentative currents recorded from
inside-out membrane patches
containing wild-type or mutant
KATP channels at 250 mV in Kint
solution (see methods). Patches
were exposed to differing [tolbu-
tamide] or 10 mM ATP, as shown.
(B) Steady state dependence of
membrane current on [tolbuta-
mide] [mean 6 SEM, relative
to current in zero tolbutamide
(Irel)] for wild-type and mutant
channels (from records such as
those shown in Fig. 1 A). Data
points represent the mean 6
SEM (n 5 3–8 patches). For all
channels, the lines are ﬁts of the
sum of two Hill components (as
in Gribble et al., 1997a), each of
the form {Irel 5 1/[1 1 ([tolbu-
tamide]/K1/2)H]} with H ﬁxed at
1.3 in each case, and the K1/2 5
2 mM (high afﬁnity) and 4.2 mM
(low afﬁnity). The relative frac-
tion of each component was var-
ied. The high-afﬁnity component
was 40, 35, and 7% for wild-
type, Kir6.2[K185Q]/SUR1, and
Kir6.2[K185Q]/SUR1 channels,
respectively. 
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As shown in Fig. 3, the latter explanation is correct;
with time after addition of PIP
 
2
 
, the dose–response re-
lationship can be ﬁt by assuming that the high afﬁnity
inhibition becomes a progressively smaller fraction of
the [tolbutamide]-inhibition relationship. Data points
at intermediate times cannot be ﬁt by assuming a con-
stant high afﬁnity fraction, with reduced afﬁnity. This is
consistent with an effect of PIP
 
2
 
 on the coupling of
high afﬁnity binding to channel inhibition, not on
modifying tolbutamide binding itself.
 
High Afﬁnity Sulfonylurea Sensitivity Depends on the 
Channel Open-State Stability
 
Since PIP
 
2
 
 and NH
 
2
 
-terminal deletion both increase
the channel open state stability (Fan and Makielski,
1997; Shyng and Nichols, 1998; Koster et al., 1999), the
loss of high afﬁnity tolbutamide sensitivity in NH
 
2
 
-ter-
minal truncated channels, and on wild-type channels
treated with PIP
 
2
 
 suggests that the coupling of high af-
ﬁnity tolbutamide binding (at SUR1; Aguilar-Bryan et
al., 1995) to channel inhibition may also depend on
 
the open-state stability. To examine this possibility fur-
ther, we have measured the tolbutamide sensitivity of
channels expressed from Kir6.2[R176A]
 
1
 
SUR1, and
Kir6.2[L164A
 
1
 
SUR1] channels, which have intrinsically
very low, and high, open-state stabilities, respectively
(Shyng and Nichols, 1998). Kir6.2[R176A]
 
1
 
SUR1
channels have a much lower intrinsic open probability
in the absence of ATP (
 
P
 
ozero
 
 
 
, 
 
0.1) than wild-type
channels (
 
P
 
ozero
 
 
 
z
 
 0.5), due to reduced PIP
 
2
 
 afﬁnity
(Fan and Makielski, 1997; Huang et al., 1998; Shyng
and Nichols, 1998). As shown in Fig. 4 A, it is clear that
these channels have a larger high afﬁnity component
of tolbutamide inhibition than wild-type channels, but
which is again lost as 
 
P
 
ozero
 
 increases after treatment
with PIP
 
2
 
 (Fig. 4 B). In contrast, Kir6.2[L164A]
 
1
 
SUR1
channels have a very high Pozero (.0.85), correspond-
ing to an intrinsic ATP sensitivity of K1/2,ATP z 1mM
(data not shown), due to the open-state stabilizing ef-
fect of this mutation. As shown in Fig. 4 A, there is es-
sentially no high afﬁnity component of tolbutamide in-
hibition of Kir6.2[L164A]1SUR1 channels. On average,
100 mM tolbutamide inhibited wild-type Kir6.21SUR1,
Figure 2. PIP2 abolishes high-
afﬁnity tolbutamide inhibition of
Kir6.21SUR1 channels. (A) Rep-
resentative currents from inside-
out patches containing wild-
type (Kir6.21SUR1) or Kir6.2
[DN2-30]1SUR1 channels. The
patches were exposed to [tolbu-
tamide], [ATP], or [PIP2] as in-
dicated. The dashed line indi-
cates zero current (determined
in 5 mM ATP). (B) Percent tol-
butamide inhibition versus time
in PIP2 for four individual patches
containing wild-type KATP chan-
nels. (C) Percent inhibition by
ATP or tolbutamide before (Pre-
control) or after (Post PIP2) ap-
plication of PIP2 (2–4 min) from
patches in B. (D) Plot of the
change in percent tolbutamide
inhibition versus change in
K1/2,ATP after application of PIP2
for patches from B.207 Koster et al.
Kir6.2[L164A]1SUR1, and Kir6.2[R176A]1SUR1 chan-
nels by 33 6 3, 3 6 2, and 77 6 6%, respectively (n 5 3
in each case).
MgADP Stimulation and Diazoxide Stimulation of Channel 
Activity Disappears with PIP2 Stimulation
Activation of wild-type Kir6.21SUR1 channels by
MgADP and diazoxide, at a ﬁxed [ATP], is quite vari-
able from patch to patch (Figs. 5 B and 6 B). As shown
in Figs. 5 A and 6 A, the ability of these agents to stimu-
late channel activity changes after PIP2 stimulation, and
in a qualitatively similar way for both Kir6.2[DN2-
30]1SUR1 and wild-type (Kir6.21SUR1) channels. In
each case, the stimulation tends to increase, but then
gradually falls to zero with time after PIP2 application.
The time course of this effect is also quite variable from
patch to patch (Figs. 5 B and 6 B), but is reasonably
well correlated with the accompanying change of ATP
sensitivity (Figs. 5 D and 6 D). This result indicates that
the stimulatory action of the PCOs, like ATP sensitivity
itself, is not a ﬁxed parameter of channel function, but
is probably dependent on the open-state stability of the
channel (Shyng and Nichols, 1998). As PIP2 increas-
ingly stabilizes the open state of the channel, sojourns
in an ATP-accessible closed state become less and less
frequent (Baukrowitz et al., 1998; Shyng and Nichols,
1998). The present results are also consistent with
PCOs acting by shifting the equilibrium between the
open and closed states (see Shyng et al., 1997b), such
that as the channel open-state stability approaches max-
imal, the stimulatory effect of the PCOs saturates.
PIP2-induced Loss of Coupling Can Be Partially Restored with 
Poly-L-lysine Treatment
Treatment with polycations can reverse the stimulatory
actions of PIP2 on open probability and ATP sensitivity
(Deutsch et al., 1994; Shyng and Nichols, 1998), proba-
bly by shielding the negative charges introduced by
PIP2. As shown in Fig. 7, some reversal of both tolbuta-
mide insensitivity and loss of PCO action is observed
Figure 3. Mechanism of the PIP2-induced loss
of tolbutamide block. (A) Representative current
recorded from inside-out membrane patches con-
taining wild-type KATP channels exposed to differ-
ing [tolbutamide] or 30 mM ATP, as shown. The
gaps in the record are 4.5, 2, and 1 min. The
dashed line indicates zero current (determined in
5 mM ATP). (B) Plot of relative current (Irel) ver-
sus [tolbutamide] for trace segments shown in A,
both before (d) and with time after (s) PIP2 ap-
plication. Data at 10 mM tolbutamide are from
control and 10-min time points. Fitted lines corre-
spond to a least squares ﬁt of the sum of two Hill
equations as described in Fig.1, with the fraction
of high afﬁnity inhibition allowed to vary (37, 23,
13, 4, 0% at 0, 4.5, 7, 8 and 10 min) as indicated,
after PIP2 application. The insert shows data only
at 7 min. The dashed lines correspond to (A,
dashed) the same curve as above, and (B, dotted)
a least squares ﬁt of the sum of two Hill equations,
with the fraction of high afﬁnity inhibition held
constant at 37%, but with the afﬁnity (i.e., K1/2)
allowed to vary. It is clear that high afﬁnity block
disappears because the high afﬁnity fraction dis-
appears, not because there is a change in the sen-
sitivity of this component.208 PIP2 Regulation of KATP Channel
when patches are subsequently treated with poly-l-
lysine. However, some irreversible loss of high afﬁnity
tolbutamide sensitivity, as well as of diazoxide and
MgADP stimulation, also occurs after prolonged PIP2
treatment, such that poly-l-lysine may only partially re-
store the SUR1 coupling (e.g., Fig. 7 A), even though
ATP sensitivity can be restored to, or beyond, control
levels (see discussion).
discussion
Loss of High Afﬁnity Tolbutamide Sensitivity with Increased 
Open Probability
A biphasic dose–response relationship for tolbutamide
inhibition of KATP channels was demonstrated by Grib-
ble et al. (1997a), but the mechanistic basis was not
made clear. When the high afﬁnity component is satu-
rated, there is an z40% reduction of wild-type cur-
rents. The high afﬁnity binding of sulfonylureas is to
the SUR1 subunit (Aguilar-Bryan et al., 1995; Gribble
et al., 1997a), and channel inhibition results from an
allosteric effect on the channel. By contrast, the low af-
ﬁnity inhibitory effect results from a direct interaction
with the Kir6.2 subunit itself (Gribble et al., 1997a),
and might be a pore-blocking action. The present re-
sults demonstrate that the high afﬁnity, physiologically
relevant, action can be abolished by increasing the
open state stability (and hence Pozero) with PIP2, or by
deleting the channel NH2 terminus. Kir6.2[DN2-30]
channels, which have an intrinsically higher open state
stability (Koster et al., 1999), show essentially no high
afﬁnity tolbutamide sensitivity (Fig. 1). Hence, al-
though the high afﬁnity sulfonylurea binding site is
clearly on the SUR1 subunit (Aguilar-Bryan et al.,
1995), the inhibitory effect on KATP channel activity will
depend critically on the functional state and molecular
nature of the Kir subunit. This prediction is dramati-
Figure 4. High afﬁnity tolbuta-
mide sensitivity depends on
open-state stability. (A) Repre-
sentative currents recorded from
inside-out membrane patches
containing wild-type or mutant
KATP channels at 250 mV in Kint
solution. Patches were exposed
to differing [tolbutamide] or 5
mM ATP, as shown. (B) Current
recorded from representative
patch containing Kir6.2
[R176A]1SUR1 channels at 250
mV in Kint solution. The patch
was exposed to differing [tol-
butamide], ATP, or 5 mg/ml PIP2,
as shown. The dashed lines rep-
resent 12- and 2-min gaps.209 Koster et al.
cally borne out by the results (Fig. 4), which show that a
mutant with even higher intrinsic open-state stability
(Kir6.2[L164A]), is almost completely insensitive to
tolbutamide, with no high-afﬁnity inhibition. By con-
trast, in a mutant with intrinsically low open probability
(Kir6.2[R176A]), putatively due to reduced PIP2 afﬁn-
ity, tolbutamide sensitivity is almost all high afﬁnity, un-
der ambient conditions after patch isolation. However,
subsequent treatment with PIP2 still abolishes high af-
ﬁnity tolbutamide inhibition, as the open-state stability
increases to, and beyond, that of the wild-type channel
(i.e., the open probability increases and K1/2,ATP de-
creases; Fig. 4 B).
The present ﬁndings are signiﬁcant for understand-
ing sulfonylurea sensitivity of KATP channels. They dem-
onstrate that sulfonylurea sensitivity will depend criti-
cally on the open-state stability of the channels (mani-
fested by open probability in the absence of ATP1).
This can change dramatically in inside-out membrane
patches as a consequence of “run down” and “run up.”
Run down is a gradual, variable, and probably multifac-
torial, reduction of channel activity, often associated
with decreased open probability and increased K1/2,ATP
(Thuringer and Escande, 1989; Deutsch and Weiss,
1993). A signiﬁcant mechanism of run down is proba-
bly decreasing levels of phosphorylated phosphatidyl
inositols in the cell membrane. Such run down can be
reversed, and the channels run up, by application of ex-
ogenous PIP2 (Baukrowitz et al., 1998; Shyng and Nichols,
1998), MgATP (Takano et al., 1990), and by application
of MgUDP (Tung and Kurachi, 1993; Terzic et al.,
1994). Interestingly, Brady et al. (1998) reported an
“operative condition-dependent response” of KATP
channels to sulfonylureas, in which stimulation of
channel activity by MgUDP led to a loss of glibencla-
mide sensitivity, but only if the channels had not previ-
ously run down. It is likely that in vivo variability of ATP
sensitivity (Findlay and Faivre, 1991) reﬂects cell-to-cell
Figure 5. PIP2 effect on
MgADP stimulation from cells
expressing Kir6.21SUR1 and
Kir6.2[DN2-30]1SUR1 chan-
nels. (A) Representative currents
from inside-out patches contain-
ing wild-type (Kir6.21SUR1) or
Kir6.2[DN2-30]1SUR1 chan-
nels. The patches were exposed
to MgADP, MgATP, or PIP2 as in-
dicated. The dashed line repre-
sents zero current determined in
5 mM ATP. (B) Plot of the per-
cent MgADP stimulation versus
time in PIP2 for ﬁve individual
patches containing wild-type KATP
channels. Percent MgADP stimu-
lation was determined by calcu-
lating the increase in current in
the presence of MgADP and
MgATP relative to current in
MgATP alone, and then express-
ing this value as a fraction of the
maximal current observed in the
absence of ATP. (C) Percent
stimulation by MgADP and inhi-
bition by ATP before (Precon-
trol) or after (Post PIP2) applica-
tion of PIP2 (3–20 min) from
patches in B. (D) Percent MgADP
stimulation versus K1/2,ATP after
application of PIP2 to wild-type
patches from B.210 PIP2 Regulation of KATP Channel
variability of the open state stability, resulting in turn
from variability of membrane phospholipid levels. Sim-
ilarly, in vivo variability of sulfonylurea sensitivity under
different conditions (Findlay, 1993; Venkatesh et al., 1991;
Mukai et al., 1998) is also likely to reﬂect changes in
open-state stability and accessibility of the closed channel.
PIP2 Activation Masks PCO Actions
It is clear that PIP2 activation of KATP channels and
other inward rectiﬁers does not require the presence of
a SUR1 subunit, and probably results from a direct in-
teraction of PIP2 with the cytoplasmic portion of the
channel protein itself (Hilgemann and Ball, 1996; Fan
and Makielski, 1997; Baukrowitz et al., 1998; Huang et
al., 1998; Shyng and Nichols, 1998). The present results
indicate that PCO sensitivity, like ATP sensitivity (Bauk-
rowitz et al., 1998; Shyng and Nichols, 1998) is a vari-
able, dynamically dependent on membrane phospho-
lipid levels rather than a ﬁxed parameter. After PIP2 ap-
plication to inside-out patches, there is generally ﬁrst
an increase in the stimulatory action of PCOs, and then
a gradual disappearance of their action as the PIP2
stimulation saturates, such that, even though ATP inhi-
bition is still observable at high concentrations, there is
no relief of this inhibition by PCOs (Figs. 5 and 6). As
discussed in Shyng and Nichols (1998) and Baukrowitz
et al. (1998), it is likely that membrane phospholipid
levels are variable from cell to cell, and that such vari-
ability accounts for the cell-to-cell variability of ATP
sensitivity that is observed physiologically (Findlay and
Faivre, 1991). By the same reasoning, the variable stim-
ulatory action of PCOs (see, e.g., Figs. 5 B and 6 B)
might be a result of cell-to-cell variability of membrane
Figure 6. PIP2 effect on diazox-
ide stimulation from cells ex-
pressing Kir6.21SUR1 and
Kir6.2[DN2-30]1SUR1 chan-
nels. (A) Representative currents
from inside-out patches contain-
ing wild-type (Kir6.21SUR1) or
Kir6.2[DN2-30]1SUR1 chan-
nels. The patches were exposed
to diazoxide and MgATP, or PIP2
as indicated. The dashed line
represents zero current deter-
mined in 5 mM ATP. (Top)
Open probability, estimated
from noise analysis of 10 s of cur-
rent in zero ATP, is indicated.
(B) Plot of the percent diazoxide
stimulation versus time in PIP2
for ﬁve individual patches con-
taining wild-type KATP channels.
Percent diazoxide stimulation
was determined by calculating
the increase in current in the
presence of diazoxide and
MgATP relative to current in
MgATP alone, and then express-
ing this value as a fraction of the
maximal current observed in the
absence of ATP. (C) Percent
stimulation by diazoxide and in-
hibition by ATP before (Precon-
trol) or after (Post PIP2) applica-
tion of PIP2 (3–20 min) from
patches in B. (D) Percent diazox-
ide stimulation versus K1/2,ATP af-
ter application of PIP2 to patches
from B.211 Koster et al.
phospholipid levels. The results raise the question:
How does the membrane phospholipid level determine
the PCO sensitivity? One possibility is that PIP2 affects
ATP hydrolysis, or PCO binding to the SUR1 subunit.
However, as we have previously suggested (Shyng et al.,
1997b), it seems likely that PCOs act ultimately to stabi-
lize the open state of the channel itself, just as the phos-
pholipids do. Therefore, the lack of PCO effects after
elevation of phospholipids, is likely to be a conse-
quence of the convergent action of these two agents on
the energetic stability of the open state relative to the
ATP-accessible closed state.
The Role of SUR Subunits in Controlling KATP 
Channel Function
It is now clear that the pore-forming (Kir6.2) subunits
can generate ATP-sensitive K channels in the complete
absence of expressed SUR subunits, even without trun-
cation of the COOH terminus (Tucker et al., 1997;
John et al., 1998; Mikhailov et al., 1998). So, what is the
role of the SUR1 subunit? Clearly, there is evidence for
a chaperoning action to bring the channel to the sur-
face, and with which SUR1 remains in physical proxim-
ity (Clement et al., 1997; John et al., 1998; Zerangue et
al., 1999). Moreover, the physiologically, and pharma-
Figure 7. PIP2 effect on tol-
butamide and PCO sensitivity is
partially reversed by application
of poly-l-lysine. (A) Current re-
corded from representative in-
side-out membrane patch con-
taining wild-type channels at 250
mV in Kint solution. The patch
was exposed to differing [tolbu-
tamide] or ATP, as shown. The
dashed line represents a 28-min
gap in the trace, during which
time PIP2 (5mg/ml) was applied.
After PIP2 application, poly-l-
lysine (10 mg/ml) was applied as
indicated. ATP and tolbutamide
sensitivity as a function of time is
shown below. Sensitivity was as-
sessed as the activity remaining
in ATP or tolbutamide relative to
maximal current in zero ATP,
zero tolbutamide. (B) Current
recorded from representative in-
side-out membrane patch con-
taining wild-type channels at 250
mV in Kint solution. The patch
was exposed to MgATP and diaz-
oxide, as indicated. The dashed
lines represent 18- and 13-min
gaps in the trace, during which
time PIP2 and poly-l-lysine, re-
spectively, were applied.212 PIP2 Regulation of KATP Channel
cologically, important regulators of the channel seem
to act through an interaction with the SUR1 subunit
(Aguilar-Bryan et al., 1995; Schwanstecher et al., 1998).
The balance of evidence suggests that ATP hydrolysis at
the nucleotide binding folds activates the channel, and
that this activation is stabilized by binding of MgADP
and other PCOs to the SUR1 subunit (Nichols et al.,
1996; Gribble et al., 1997b; Shyng et al., 1997a,b; Schwan-
stecher et al., 1998). High-afﬁnity sulfonylurea binding
is to the SUR subunit (Aguilar-Bryan et al., 1995), and
this effect is then transduced to inhibition of channel
activity. The physical nature of the coupling between
SURx and the Kir6.x subunits and the interacting re-
gions of each subunit remain unknown. The present
results show that deletion of the NH2 terminus of
Kir6.2 can functionally uncouple the high afﬁnity tol-
butamide sensitivity from the channel. However, it is
clear that PCO actions on the channel remain for the
NH2-terminus truncated channel so that a physical cou-
pling is still intact.
High afﬁnity sulfonylurea sensitivity and PCO sensi-
tivity is conferred by the SUR1 subunit, and is absent
for Kir6.2 channels expressed in the absence of SUR1
(Gribble et al., 1997a; Tucker et al., 1997), which begs
the question whether the effect of PIP2 is to cause a
physical, or functional, uncoupling of Kir6.2 from
SUR1. A physical uncoupling seems unlikely based on
the observation that treatment with polylysine leads to
(a) some reversal of the PIP2 abolition of pharmacolog-
ical regulation, and (b) full restoration of the SUR1-
dependent K1/2,ATP of z10 mM. Nevertheless, we cannot
exclude the possibility that the PIP2 action physically in-
terrupts the transduction of the inhibitory signal from
SUR1 to Kir6.2.
Conclusions
High afﬁnity tolbutamide inhibition seems, like ATP in-
hibition, to be the result of a closed state stabilization,
but, unlike ATP inhibition, is not likely to be a direct
binding to the closed channel. Stabilizing the open
state and raising the channel open probability, either
by mutation or by application of PIP2, reduces high af-
ﬁnity tolbutamide sensitivity. Similarly, PCOs act on
SUR1 to stabilize the channel in the open state, conver-
gent with PIP2 action, such that PIP2 treatment leads to
channel activation without further activation in the
presence of PCOs. Treatment with polylysine causes at
least partial reversal of the uncoupling actions of PIP2
effect, restoring some high afﬁnity tolbutamide sensitiv-
ity and PCO stimulation. These results indicate that, in
native cells, the pharmacological and physiological
control of channel activity by the SUR1 subunit will be
critically dependent on the open-state stability, itself de-
termined by the phospholipid content of the mem-
brane.
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